Kevin M Gray1, Lindsay M Squeglia1. 1. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Abstract
BACKGROUND: Adolescence is a critical biological, psychological, and social developmental stage involving heightened risk for substance use and associated adverse consequences. This review, synthesizing emerging findings on this complex topic, is intended to inform research and clinical care focused on adolescents. METHODS: Literature searches were conducted using PubMed, yielding a cross-section of observational and interventional studies focused on adolescent substance use. Findings were organized and categorized to cover key areas of epidemiology, neurobiology, prevention, and treatment. FINDINGS: Adolescent substance-related attitudes and use patterns have evolved over time, informed by adult and peer behaviors, public policy, media messaging, substance availability, and other variables. A number of risk and resiliency factors contribute to individual differences in substance use and related consequences. Advances in observational techniques have provided enhanced understanding of adolescent brain development and its implications for substance use. Prevention efforts have yielded mixed results, and while a number of adolescent-targeted evidence-based treatments for substance use disorders have been developed, effect sizes are generally modest, indicating the need for further research to enhance prevention and treatment outcomes. CONCLUSIONS: Substance use in adolescence is heterogeneous, ranging from normative to pathological, and can lead to significant acute and long-term morbidity and mortality. Understanding risk and resiliency factors, underlying neurobiology, and optimal developmentally sensitive interventions is critical in addressing substance-associated problems in adolescence.
BACKGROUND: Adolescence is a critical biological, psychological, and social developmental stage involving heightened risk for substance use and associated adverse consequences. This review, synthesizing emerging findings on this complex topic, is intended to inform research and clinical care focused on adolescents. METHODS: Literature searches were conducted using PubMed, yielding a cross-section of observational and interventional studies focused on adolescent substance use. Findings were organized and categorized to cover key areas of epidemiology, neurobiology, prevention, and treatment. FINDINGS: Adolescent substance-related attitudes and use patterns have evolved over time, informed by adult and peer behaviors, public policy, media messaging, substance availability, and other variables. A number of risk and resiliency factors contribute to individual differences in substance use and related consequences. Advances in observational techniques have provided enhanced understanding of adolescent brain development and its implications for substance use. Prevention efforts have yielded mixed results, and while a number of adolescent-targeted evidence-based treatments for substance use disorders have been developed, effect sizes are generally modest, indicating the need for further research to enhance prevention and treatment outcomes. CONCLUSIONS: Substance use in adolescence is heterogeneous, ranging from normative to pathological, and can lead to significant acute and long-term morbidity and mortality. Understanding risk and resiliency factors, underlying neurobiology, and optimal developmentally sensitive interventions is critical in addressing substance-associated problems in adolescence.
Authors: Lindsay M Squeglia; Carmen Pulido; Reagan R Wetherill; Joanna Jacobus; Gregory G Brown; Susan F Tapert Journal: J Stud Alcohol Drugs Date: 2012-09 Impact factor: 2.582
Authors: Amy E Ramage; Ai-Ling Lin; Rene L Olvera; Peter T Fox; Douglas E Williamson Journal: Drug Alcohol Depend Date: 2015-01-20 Impact factor: 4.492
Authors: Kevin M Gray; Matthew J Carpenter; Nathaniel L Baker; Karen J Hartwell; A Lee Lewis; D Walter Hiott; Deborah Deas; Himanshu P Upadhyaya Journal: J Subst Abuse Treat Date: 2010-10-08
Authors: Lindsay M Squeglia; Susan F Tapert; Edith V Sullivan; Joanna Jacobus; M J Meloy; Torsten Rohlfing; Adolf Pfefferbaum Journal: Am J Psychiatry Date: 2015-05-18 Impact factor: 18.112
Authors: Robert Whelan; Richard Watts; Catherine A Orr; Robert R Althoff; Eric Artiges; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Christian Büchel; Fabiana M Carvalho; Patricia J Conrod; Herta Flor; Mira Fauth-Bühler; Vincent Frouin; Juergen Gallinat; Gabriela Gan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Claire Lawrence; Karl Mann; Jean-Luc Martinot; Frauke Nees; Nick Ortiz; Marie-Laure Paillère-Martinot; Tomas Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Andreas Ströhle; Gunter Schumann; Hugh Garavan Journal: Nature Date: 2014-07-02 Impact factor: 49.962
Authors: Lindsay M Squeglia; Matthew C Fadus; Erin A McClure; Rachel L Tomko; Kevin M Gray Journal: J Child Adolesc Psychopharmacol Date: 2019-04-22 Impact factor: 2.576
Authors: Alyssa Lozano; Feifei Liu; Tae Kyoung Lee; Guillermo Prado; Seth J Schwartz; Adam M Leventhal; Annemarie R Kelleghan; Jennifer B Unger; Jessica L Barrington-Trimis Journal: Drug Alcohol Depend Date: 2020-12-31 Impact factor: 4.492
Authors: Emily K Leiker; Harma Meffert; Laura C Thornton; Brittany K Taylor; Joseph Aloi; Heba Abdel-Rahim; Niraj Shah; Patrick M Tyler; Stuart F White; Karina S Blair; Francesca Filbey; Kayla Pope; Matthew Dobbertin; R James R Blair Journal: Psychiatry Res Neuroimaging Date: 2019-09-12 Impact factor: 2.376
Authors: Matthew C Fadus; Lindsay M Squeglia; Emilio A Valadez; Rachel L Tomko; Brittany E Bryant; Kevin M Gray Journal: Curr Psychiatry Rep Date: 2019-09-14 Impact factor: 5.285
Authors: Natasha E Wade; Kara S Bagot; Claudia I Cota; Aryandokht Fotros; Lindsay M Squeglia; Lindsay R Meredith; Joanna Jacobus Journal: J Psychopharmacol Date: 2019-06-19 Impact factor: 4.153